
Found Review
Also known as Found Health
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.3/10
Best for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
Found scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $289/mo ongoing
Tirzepatide
then $359/mo ongoing
Price checked on Found’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not stated
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
PartnerFound is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
Found is a weight-care membership that works with many insurance plans for clinical visits and offers a wide medication menu, including non-GLP-1 options. Compounded medication is included in the plan price. Its Offer Terms put compounded semaglutide at $169/mo cash on a 12-month plan paid upfront ($289 month to month) and tirzepatide at $239 ($359), billed every 28 days, while its marketing pages advertise plans from $149/mo cash. Brand GLP-1s such as Wegovy, Zepbound and Foundayo are billed separately from the membership.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Found at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $289/4 wks (billed per 4 weeks) ($179 first month)
- What's included
- Medication · Consult · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Found
Each dimension is scored algorithmically from Found’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $289/mo (per 4 weeks), Found runs about 61% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $179.
Effectiveness25%
9.4/10Found offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
8.1/10Online intake and platform experience (consult included in the price); 3 platform features disclosed.
Trust & Safety15%
9.1/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
9.3/10Found treats patients in all 50 states.
Support10%
8.2/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Found review
Last checked November 2026- Confirmed current pricing across 7 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $149–$359/mo across 7 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Found
We walked Found’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health assessment.
- 2A clinician reviews your profile to determine eligibility.
- 3If eligible, medication is shipped to your door within roughly one week.
- 4Ongoing personalized care with monthly check-ins from the care team.
- Prices are shown publicly before intake, but they disagree: the marketing pages say plans from $79/mo with insurance or $149/mo cash on 12-month plans, while the Offer Terms list compounded semaglutide from $99/mo with insurance or $169/mo cash and tirzepatide from $179 or $239. Non-GLP-1 options start at $49/mo.
- States clinical-care cost may be lower with insurance ('most members pay less than $30/visit').
- Refund terms sit in the Offer Terms: a full membership refund within three days of purchase or before the first consult; medication and renewals are non-refundable.
- Medication is described as shipped to the door, approximately one week after review.
- Support is via a Help Center; no phone number is listed and contact emails are obfuscated.
- A site banner offers 'up to $100 off your membership plan today' (one-time, Med Kit plans excluded, no end date), and the Offer Terms add an automatic first-month discount on 1-month plans.
GLP-1 medications Found offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$169/mo cash on a 12-month prepaid plan ($249 on 3 months, $219 on 6), medication and coaching included; each charge covers 28 days. Found's marketing pages advertise lower 'from $149/mo' cash plans.
Cash pay. New members on a 1-month plan get an automatic $110 off the first month: $179 for the first month, then $289 per 28-day cycle. Medication, membership and coaching included.
$239/mo cash on a 12-month prepaid plan ($309 on 3 months, $289 on 6), medication and coaching included; each charge covers 28 days. Found's marketing pages advertise lower 'from $149/mo' cash plans.
Cash pay. New members on a 1-month plan get an automatic $140 off the first month: $219 for the first month, then $359 per 28-day cycle. Medication, membership and coaching included.
The comparison table on Found's Foundayo page lists a 'Starting cash price ~$149/mo'. Found's homepage notes the cost 'does not include the subscription fees and clinical care', so the Found membership is billed separately.
Found's comparison table lists the Wegovy pen from ~$199/mo (pill ~$149/mo), $149–$349/mo by dose. Medication only: a separate branded-plan membership starts at $49/mo.
Found's comparison table lists Zepbound from ~$299/mo, $299–$449/mo by dose. Medication only: a separate branded-plan membership starts at $49/mo.
Ready to get started?
Plans and promotions change often, so check Found's current pricing and active discounts before you decide.
What we like
- Compounded medication included in the plan price
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- The $169 cash rate is a 12-month plan paid upfront; month to month is $289
- Marketing pages advertise plans from $149/mo cash, but the Offer Terms list semaglutide at $169 and tirzepatide at $239 on 12-month plans
- Month-to-month plans bill every 28 days, so a year is 13 charges, not 12
- Brand-name GLP-1 medication is billed separately from the membership
- Compounded tirzepatide costs more than semaglutide: $239/mo cash on a 12-month plan, $359 month to month
Found: a membership-first weight platform built for the mainstream
Found is one of the more recognizable names in the GLP-1 telehealth crowd, and it earns that profile by being broad rather than boutique. It runs as a personalized weight-care membership available in all 50 states, pairing a low monthly entry price with compounded semaglutide and tirzepatide. If you want a well-rounded program that treats medication as one piece of a bigger behavior-change picture, and you don't want to overthink whether the service reaches your state, Found is a sensible default. It is less the right pick for someone hunting the single cheapest vial or someone who insists on brand-name pens from day one.
How the membership-plus-medication pricing works
The thing to understand about Found is that you are buying a membership, and the membership is where the compounded medication lives. Found's own plans-and-pricing page states that compounded medications are included in the cost of both its insurance and cash-pay plans. So the monthly figure you see is meant to cover the program and the compounded drug together, not as two separate line items. The entry rate is $289 (per 4 weeks), which requires paying for a full year upfront, so it doesn't compare like for like with the $179 median of month-to-month prices. That figure is for semaglutide. Found's Offer Terms now price tirzepatide separately, at $239 a month on the same 12-month plan and $359 month to month. Its marketing pages advertise plans “from $149/mo” cash, a figure the Offer Terms don't show for either drug, so check the price at checkout.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
There's an important caveat baked into that bundle. Branded GLP-1s are not part of the included price. If you and your clinician decide you want a name-brand pen instead of a compounded formulation, that medication is billed separately and the cost climbs steeply. Brand-name GLP-1 therapy runs from the mid-hundreds to well over a thousand dollars a month depending on the specific drug. So the headline $289 (per 4 weeks) only holds while you stay on the compounded track.
Found now runs a first-month discount on its 1-month plans. New cash-pay members pay $179 for the first month of semaglutide, then $289, or $219 for the first month of tirzepatide, then $359. A site banner also offers a one-time discount on a membership plan at checkout. Plan around the month-two price, not the first charge.
The medications and how they're dispensed
On the cash-pay side, Found leans on compounded semaglutide and compounded tirzepatide, the same two active ingredients behind Wegovy/Ozempic and Zepbound/Mounjaro, prepared by a compounding pharmacy rather than the original manufacturer. Having both available matters: tirzepatide and semaglutide behave differently, and a provider that stocks both gives your clinician room to switch if one stalls or causes side effects. Needle-free formats are the draw at ShedRx, which sells compounded GLP-1s as drops and lozenges as well as shots.
Found can also prescribe the branded medications: Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza. It maintains an interactive insurance map showing carrier availability by state, which is a useful tool if you're hoping to get a brand pen covered through your plan. Just remember those branded options sit outside the bundled membership price.
What sets Found apart
Plenty of providers compound the same molecules, so the drug is not what sets Found apart. Its differentiator is how much non-drug program comes attached. Every plan includes full access to a licensed medical team, and the membership wraps in behavioral guidance, an AI companion for between-visit support, and a member community. Coaching and clinical contact are built in, not sold as add-ons. For people who have learned the hard way that a prescription alone doesn't change habits, that scaffolding is the reason to choose Found over a bare-bones pharmacy-style service.
- Compounded semaglutide and tirzepatide included in the membership price
- Licensed medical team access on every plan
- Behavioral coaching, an AI companion, and a member community built in
- Both insurance and cash-pay pathways, with a state-by-state coverage map
- Nationwide availability across all 50 states
Complaints, refunds & cancellation
Found is the trading name of Found Health, Inc., and its refund terms sit inside its Offer Terms, last updated August 26, 2025. The membership fee comes back in full if you cancel within three days of buying or before your first medical consultation. After either point, it is non-refundable, whether or not you used anything. A full refund also applies if a clinician rules you out of every treatment Found offers. Being ruled out of one drug, such as your preferred GLP-1, doesn't count while other options remain.
Medication and lab kits can't be returned or refunded once they are dispensed or shipped. Insurance co-pays are also final. Renewal payments are non-refundable, so cancel or pause at least 48 hours before the renewal date. A missed consultation, or one canceled with less than 24 hours' notice, carries a no-show fee. Found warns that a chargeback may affect your eligibility to keep getting care, and approved refunds can take up to 30 days. On Trustpilot, Found's profile showed 4.2 out of 5 from 776 reviews in October 2026, with 18% of them one-star.
Who should pick Found, and who should skip it
Choose Found if you want an all-in-one program (medication, clinician, and habit support in one membership) and you value reliability and reach over chasing the rock-bottom price. It's also a strong option if you might want to run your insurance benefits, given the coverage map and the dual insurance/cash-pay plans.
Skip it if you're a price-only shopper who wants the cheapest possible compounded vial with no membership wrapper, or if your priority is a brand-name pen, because the moment you move off compounded, the separate medication billing erases Found's pricing advantage. For one rate at every dose without a coaching program, bmiMD is a simpler alternative. It's also not the best fit if you want every program detail spelled out before you sign up. Found publishes less granular information about visit cadence, dosing schedules, and refund terms than some competitors, so you'll likely need to confirm specifics with their team.
Trust, safety, and medical oversight
Found has no FDA warning letters on file, and clinical oversight is a stated part of every plan via its licensed medical team, which is a reassuring baseline. Two gaps hold it back. Found doesn't publicly name the compounding pharmacy behind its formulations, though it says it works only with 503A-licensed pharmacies and that its compounded semaglutide is third-party tested for potency, purity, and sterility before it ships. Its public program documentation is also thinner than average. On insurance plans, note that included visits may still carry copays. None of that is a red flag, but ask about these details directly before your first charge.
Bottom line
Found is a solid, mainstream choice: nationwide access, a low $289 (per 4 weeks)-a-month entry on compounded GLP-1s, both major molecules on the menu, and a coaching-and-community program wrapped around the prescription. The trade-offs are limited public transparency and a price advantage that only holds on the compounded track. If you want a dependable, well-supported program and you're comfortable on compounded medication, Found is easy to recommend. For more on how we weigh price, access, and oversight, see our scoring methodology.
The Bottom Line
Found scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Found?
From $289/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
Alternatives to Found
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare Found vs…
Found scores8.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
Found vs Enhance MD
Enhance MD scores 8.2/10

Found vs Mochi Health
Mochi Health scores 7.7/10

Found vs Ro
Ro scores 7.7/10

Found vs Henry Meds
Henry Meds scores 7.3/10

Found vs Eden
Eden scores 7.2/10

Found vs Hims
Hims scores 7.1/10
All 49 Found comparisons
- Found vs AgelessRx
- Found vs altRX
- Found vs Amazon One Medical
- Found vs Belle Health
- Found vs bmiMD
- Found vs Bodybuilding Health+
- Found vs Brightmeds
- Found vs Collective
- Found vs CoreAge Rx
- Found vs Direct Meds
- Found vs DudeMeds
- Found vs Embody
- Found vs EverSlim
- Found vs Gala
- Found vs GobyMeds
- Found vs HealthRX
- Found vs HumeCare+
- Found vs Ivim Health
- Found vs Live Vital
- Found vs Lttl
- Found vs Luvo Health
- Found vs MadeMed
- Found vs MangoRx
- Found vs Maximus
- Found vs MEDGm
- Found vs MEDVi
- Found vs Midi Health
- Found vs NewSelf
- Found vs Oak
- Found vs PlexusDx
- Found vs RxSpan MD
- Found vs Sesame Care
- Found vs ShedRx
- Found vs SkinnyRx
- Found vs SnagRx
- Found vs Sprout Health
- Found vs Strut Health
- Found vs TMates
- Found vs TrimRx
- Found vs Vytora Health
- Found vs Wellorithm
- Found vs YourEra
- Found vs Zealthy
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Found review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Found's current pricing
Plans from $289/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.